Bhumsuk Keum

56PUBLICATIONS
229CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsTumour immunologyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (56)

|May 21, 2026
Randomized Phase II Trial of Consolidation Pembrolizumab After Definitive Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma: KCSG HN19-09, CONPELAN Study.

|Apr 10, 2026
Distribution of Immune Cells in Tumor Microenvironment Correlates With Checkpoint Inhibitor Response in Nasopharyngeal Carcinoma: A Multiregional Study.

Bhumsuk Keam, Darren Wan-Teck Lim, Hsiang-Fong Kao

|Feb 10, 2026
Clinical Characteristics Associated with High [68Ga]Ga-PSMA-11 Uptake and Preliminary Therapeutic Outcomes in Patients with Metastatic Adenoid Cystic Carcinoma.

Hyunpil Sung, Minseok Suh, Joonhyung Gil

|Jan 13, 2026
Exploratory Biomarker Analysis of Abemaciclib in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma With Dysregulated CDK4/6 Pathway.

Joo-Hwan Park, Hee Kyung Ahn, Hye Ryun Kim

|Jan 10, 2026
Neoadjuvant Concurrent Chemoradiotherapy Versus Neoadjuvant Chemotherapy in Thymic Epithelial Tumors: A Propensity Score-Matched Analysis.

Bubse Na, Chang Hyun Kang, Taeyoung Yun

|Jul 17, 2025
The Small Molecule Inhibitor of the Wnt-β-Catenin Pathway, CWP232291, Inhibits Tumor Growth in Preclinical Models of Salivary Gland Adenoid Cystic Carcinoma.

Joseph O Humtsoe, Bhumsuk Keam, Hyun-Su Kim

Pageof 10

Frequent Collaborators

14 joint publications

Shin Hyu Yoo

7 joint publications

Yoon Kyung Jeon

5 joint publications

Myung-Ju Ahn

5 joint publications

Miso Kim